NO943723L - Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes - Google Patents
Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetesInfo
- Publication number
- NO943723L NO943723L NO943723A NO943723A NO943723L NO 943723 L NO943723 L NO 943723L NO 943723 A NO943723 A NO 943723A NO 943723 A NO943723 A NO 943723A NO 943723 L NO943723 L NO 943723L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes
- quinoline
- hydrogen atoms
- treatment
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
PCT/SE1993/000272 WO1993019756A1 (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO943723D0 NO943723D0 (no) | 1994-10-05 |
NO943723L true NO943723L (no) | 1994-10-05 |
Family
ID=20385863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO943723A NO943723L (no) | 1992-04-06 | 1994-10-05 | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes |
Country Status (16)
Country | Link |
---|---|
US (1) | US5594005A (sv) |
EP (1) | EP0634931A1 (sv) |
JP (1) | JPH07506568A (sv) |
KR (1) | KR950700738A (sv) |
CN (1) | CN1081671A (sv) |
AU (1) | AU667362B2 (sv) |
CA (1) | CA2131831C (sv) |
EE (1) | EE03090B1 (sv) |
HU (1) | HUT69710A (sv) |
IL (1) | IL105285A0 (sv) |
NO (1) | NO943723L (sv) |
NZ (1) | NZ251494A (sv) |
PH (1) | PH30820A (sv) |
SE (1) | SE9201076L (sv) |
WO (1) | WO1993019756A1 (sv) |
ZA (1) | ZA932450B (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
US6133285A (en) * | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
FR2827600A1 (fr) * | 2001-07-20 | 2003-01-24 | Lipha | Derives acides de quinolone et leurs applications en therapeutique |
US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
EP2351559B1 (en) * | 2008-10-09 | 2015-08-12 | Newtree Co., Ltd. | Novel use of panduratin derivative or boesenbergia pandurata extract |
MX2013004169A (es) * | 2010-10-14 | 2013-06-05 | Immunahr Ab | 1, 2-dihidro-4-hidroxi-2-oxo-quinolina-3-carboxanilidas como activadores del receptor de hidrocarburo aromatico. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1034124A (en) * | 1973-05-11 | 1978-07-04 | Ciba-Geigy Ag | Process for the manufacture of new quinolines |
FR2340735A1 (fr) * | 1976-02-11 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
DE3134780A1 (de) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
US5310913A (en) * | 1989-06-09 | 1994-05-10 | Kabi Pharmacia Aktiebolag | Derivatives of quinoline-3-carboxanilide |
SE9000624D0 (sv) * | 1990-02-22 | 1990-02-22 | Pharmacia Ab | New use |
SE9001111D0 (sv) * | 1990-03-27 | 1990-03-27 | Pharmacia Ab | Supportive use |
-
1992
- 1992-04-06 SE SE9201076A patent/SE9201076L/sv not_active Application Discontinuation
-
1993
- 1993-03-31 HU HU9402854A patent/HUT69710A/hu unknown
- 1993-03-31 US US08/313,302 patent/US5594005A/en not_active Expired - Fee Related
- 1993-03-31 WO PCT/SE1993/000272 patent/WO1993019756A1/en not_active Application Discontinuation
- 1993-03-31 CA CA002131831A patent/CA2131831C/en not_active Expired - Fee Related
- 1993-03-31 NZ NZ251494A patent/NZ251494A/en unknown
- 1993-03-31 AU AU39131/93A patent/AU667362B2/en not_active Ceased
- 1993-03-31 JP JP5517372A patent/JPH07506568A/ja active Pending
- 1993-03-31 EP EP93908245A patent/EP0634931A1/en not_active Withdrawn
- 1993-04-02 PH PH45991A patent/PH30820A/en unknown
- 1993-04-02 IL IL105285A patent/IL105285A0/xx unknown
- 1993-04-05 ZA ZA932450A patent/ZA932450B/xx unknown
- 1993-04-05 CN CN93105195A patent/CN1081671A/zh active Pending
-
1994
- 1994-10-05 NO NO943723A patent/NO943723L/no unknown
- 1994-10-06 KR KR1019940703534A patent/KR950700738A/ko not_active Application Discontinuation
- 1994-11-17 EE EE9400269A patent/EE03090B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU667362B2 (en) | 1996-03-21 |
SE9201076L (sv) | 1993-10-07 |
CA2131831A1 (en) | 1993-10-14 |
KR950700738A (ko) | 1995-02-20 |
WO1993019756A1 (en) | 1993-10-14 |
HU9402854D0 (en) | 1995-01-30 |
PH30820A (en) | 1997-10-17 |
AU3913193A (en) | 1993-11-08 |
SE9201076D0 (sv) | 1992-04-06 |
NO943723D0 (no) | 1994-10-05 |
EP0634931A1 (en) | 1995-01-25 |
NZ251494A (en) | 1997-07-27 |
HUT69710A (en) | 1995-09-28 |
EE03090B1 (et) | 1998-06-15 |
US5594005A (en) | 1997-01-14 |
JPH07506568A (ja) | 1995-07-20 |
CA2131831C (en) | 1999-03-09 |
IL105285A0 (en) | 1993-08-18 |
ZA932450B (en) | 1993-10-20 |
CN1081671A (zh) | 1994-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2000001786A0 (en) | Therapeutic uses of quinoline derivatives. | |
NO173234C (no) | Chelatdannere til kompleksdannelse av radioaktive isotoper, deres metallkomplekser, saavel som deres anvendelse i diagnostikk | |
BR0214164A (pt) | Ligantes do receptor canabinóide | |
CA2036304A1 (en) | Pyrimidinedione derivatives, their production and use | |
NZ333302A (en) | Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor | |
YU1501A (sh) | Derivati hinolina | |
PL335518A1 (en) | 1,8-cycled n- or c-bound imidazole substituted derivatives of quinolynone inhibiting farnesil transferase | |
PL364221A1 (en) | Fused heterocyclic compounds | |
HUP9801219A2 (hu) | Triciklusos N-acilezett benzazepin és benzoxazepinszármazékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
CA2112331A1 (en) | Novel naphthalene derivatives | |
MY113733A (en) | Salts of an anti-migraine indole derivative | |
NO941273L (no) | Ny anvendelse av substituert kinolinkarboksamid | |
NO924929L (no) | Farmasoeytisk aktive benzoquinazolinforbindelser | |
NO943723L (no) | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes | |
SE9302490D0 (sv) | New use of old drugs | |
ES2126890T3 (es) | Preparacion de complejos de monociclopentadienilo con metales mediante sustitucion nucleofila de complejos de bis(ciclopentadienilo) con metales. | |
DK0613687T3 (da) | Anvendelse af pregnanderivat til behandling af tumorer | |
RU95106653A (ru) | Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе | |
SE9400809D0 (sv) | New use of quinoline-3-carboxamide compounds | |
TW344742B (en) | Indole derivatives and the medical used thereof | |
SE9400810D0 (sv) | New use of Quinoline-3-carboxamide compounds | |
EP0543018A4 (en) | Antidiabetic | |
NO914375L (no) | 7-acyl-3-(substituerte carbamoyloxy)cefem-forbindelser ogfremgangsmaate for fremstilling av disse | |
GB1252847A (sv) | ||
GB1337371A (en) | 3-amino-imidazo-1,5-a- pyridines processes for their preparation and pharmaceutical compositions incorporating them |